The impacts on constitutively active BCR::ABL1 oncogenic signaling that results in unchecked proliferation and apoptosis inhibition in CML were examined using molecular docking and molecular dynamics simulations. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.